Aclaris Therapeutics Inc logo

Aclaris Therapeutics Inc (ACRS)

$1.19

Aclaris Therapeutics Inc (ACRS) Share Price Forecast
Currently 15 wall-street analysts regularly analyze the financials of Aclaris Therapeutics Inc on a frequent basis to provide recommendations along with target share price. 15 analysts offering 12-month price forecasts for Aclaris Therapeutics Inc (ACRS) have a share price target of $1.84. This median of share price forecast represents a 54.62% upside from the latest price of $1.19 as on 22.05.24.

Aclaris Therapeutics Inc (ACRS) Price vs Consensus Price Target

Price
Target Price
As per the chart shown above, analysts believe that the Aclaris Therapeutics Inc (ACRS) share price will touch around $1.84 in next 12-months.
Aclaris Therapeutics Inc (ACRS) Share Price Forecast v/s Share Price Today
Below is a chart showing the percentage difference between Aclaris Therapeutics Inc's share price and its median forecast price. As on 22.05.24, the difference is -31.52%

Aclaris Therapeutics Inc (ACRS): Difference between Current Price & Median Forecasted Price

Difference in Percentage terms
Aclaris Therapeutics Inc (ACRS) Share Price : Analyst Recommendation
Based on 15 analysts tracking and researching Aclaris Therapeutics Inc (ACRS) share have buy recommendation on an average.

3M Ago1M AgoCurrent
Buy
7
6
7
Outperform
7
7
7
Hold
1
1
1
Underperform
0
0
0
Sell
0
0
0
Aclaris Therapeutics Inc (ACRS) Share Price Technical Analysis

50 Day Moving Average v/s Current Share Price

Moving Average
Price

200 Day Moving Average v/s Current Share Price

Moving Average
Price

FAQs

The latest share price target for Aclaris Therapeutics Inc (ACRS) is $1.84, offered by 15 analysts offering 12-month price forecasts.

Aclaris Therapeutics Inc (ACRS) has a maximum of 0.55 upside potential, based on 15 analysts offering 12-month price forecasts.

Based on 15 analysts tracking and researching Aclaris Therapeutics Inc (ACRS), 93.33% have a buy recommendation. Remaining 6.67% have either sell or hold recommendations.

The latest share price of Aclaris Therapeutics Inc (ACRS) is $1.19 as of 22/05/2024.

14 of total 15 analysts offering stock ratings for Aclaris Therapeutics Inc ACRS have recommended buy rating.